Middle East & Africa Adjuvants Market - Forecast (2021 - 2026)

Chapter 1. Middle East & Africa Adjuvants Market – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. Middle East & Africa Adjuvants Market – Executive Summary

2.1. Market Size & Forecast – (2021 – 2026) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2021 - 2026

      2.3.2. Impact on Supply – Demand

      2.3.3. Impact on Production Cost

      2.3.4. Impact on Supply Chain

Chapter 3. Middle East & Africa Adjuvants Market – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. Middle East & Africa Adjuvants Market Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porters Five Force Model

      4.4.1. Bargaining Power of Suppliers

      4.4.2. Bargaining Powers of Customers

      4.4.3. Threat of New Entrants

      4.4.4. Rivalry among Existing Players

      4.4.5. Threat of Substitutes

Chapter 5. Middle East & Africa Adjuvants Market - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. Middle East & Africa Adjuvants Market – By Source

6.1. Adjuvant Emulsions

6.2. Pathogen Components

      6.2.1. Monophosphoryl Lipid A

      6.2.2. Poly(I:C)

      6.2.3. CpG DNA Adjuvants

6.3. Particulate Adjuvants

      6.3.1. CytoKines

      6.3.2. Virosomes

      6.3.3. Alum

6.4. Combination Adjuvants

Chapter 7. Middle East & Africa Adjuvants Market – By Category

7.1. Agricultural Adjuvants

      7.1.1. By Type

            7.1.1.1. Activator Adjuvants

                  7.1.1.1.1. Surfactants

                        7.1.1.1.1.1. Ionic

                        7.1.1.1.1.2. Non-Ionic

                        7.1.1.1.1.3. Amphoteric

                  7.1.1.1.2. Oil Adjuvants

                        7.1.1.1.2.1. Vegetable Oil

                        7.1.1.1.2.2. Petroleum Oil

            7.1.1.2. Utility Adjuvants

                  7.1.1.2.1. Compatibility Agents

                  7.1.1.2.2. Buffers/Acidifiers

                  7.1.1.2.3. Antifoam Agents

                  7.1.1.2.4. Water Conditioners

                  7.1.1.2.5. Drift Control Agents

                  7.1.1.2.6. Others

      7.1.2. By Application Insights

            7.1.2.1. Herbicides

            7.1.2.2. Insecticides

            7.1.2.3. Fungicides

            7.1.2.4. Others

      7.1.3. By Crop Type

            7.1.3.1. Grains & Cereals

            7.1.3.2. Oil Seeds and Pulses

            7.1.3.3. Fruits & Vegetables

            7.1.3.4. Others

7.2. Vaccine Adjuvants

      7.2.1. By Route of Administration

            7.2.1.1. Oral Intramuscular

            7.2.1.2. Intranasal

            7.2.1.3. Subcutaneous

            7.2.1.4. Intradermal

      7.2.2. By Disease

            7.2.2.1. Cancer

            7.2.2.2. Infectious Diseases

Chapter 8. Middle East & Africa Adjuvants Market – By Application

8.1. Farming

8.2. Veterinary Medicine

8.3. Medical and Pharmacy

8.4. Research and Education

8.5. Commercial Applications

8.6. Others

Chapter 9. Middle East & Africa Adjuvants Market , By Geography – Market Size, Forecast, Trends & Insights

9.1. Middle East & Africa

      9.1.1. Kingdom of Saudi Arabia

      9.1.2. UAE

      9.1.3. Israel

      9.1.4. Rest of GCC countries

      9.1.5. South Africa

      9.1.6. Ethiopia

      9.1.7. Kenya

      9.1.8. Egypt

      9.1.9. Sudan

      9.1.10. Rest of MEA

Chapter 10. Middle East & Africa Adjuvants Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10